| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0003 |